212 related articles for article (PubMed ID: 12869036)
1. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibody profiles differ according to type of primary sclerosing cholangitis and autoimmune hepatitis.
Crescente JG; Dellavance A; Diniz MA; Carrilho FJ; Andrade LEC; Cançado ELR
Clinics (Sao Paulo); 2021; 76():e2228. PubMed ID: 33567045
[TBL] [Abstract][Full Text] [Related]
5. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
7. "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines.
Terjung B; Spengler U; Sauerbruch T; Worman HJ
Gastroenterology; 2000 Aug; 119(2):310-22. PubMed ID: 10930366
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic antibody in patients with antinuclear antibody-positive chronic hepatitis C.
Ohira H; Tojo J; Shinzawa J; Suzuki T; Miyata M; Nishimaki T; Kasukawa R
Fukushima J Med Sci; 1998 Dec; 44(2):83-92. PubMed ID: 10091380
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
[TBL] [Abstract][Full Text] [Related]
10. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.
Targan SR; Landers C; Vidrich A; Czaja AJ
Gastroenterology; 1995 Apr; 108(4):1159-66. PubMed ID: 7698584
[TBL] [Abstract][Full Text] [Related]
11. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.
Vidrich A; Lee J; James E; Cobb L; Targan S
J Clin Immunol; 1995 Nov; 15(6):293-9. PubMed ID: 8576315
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis.
Lenzen H; Weismüller TJ; Negm AA; Wlecke J; Loges S; Strassburg CP; Manns MP; Lankisch TO
Scand J Gastroenterol; 2013 Oct; 48(10):1205-12. PubMed ID: 23957616
[TBL] [Abstract][Full Text] [Related]
13. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
[TBL] [Abstract][Full Text] [Related]
14. Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
Bansi DS; Bauducci M; Bergqvist A; Boberg K; Broome U; Chapman R; Fleming K; Jorgensen R; Lindor K; Rosina F; Schrumpf E
Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):575-80. PubMed ID: 9222729
[TBL] [Abstract][Full Text] [Related]
15. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody profile of primary sclerosing cholangitis.
Gur H; Shen G; Sutjita M; Terrberry J; Alosachie I; Barka N; Lin HC; Peter JB; Meroni PL; Kaplan M
Pathobiology; 1995; 63(2):76-82. PubMed ID: 8554703
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
[TBL] [Abstract][Full Text] [Related]
18. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease with special attention for IgA-class antibodies.
Gigase P; De Clerck LS; Van Cotthem KA; Bridts CH; Stevens WJ; Van Outryve M; Pelckmans PA
Dig Dis Sci; 1997 Oct; 42(10):2171-4. PubMed ID: 9365154
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]